One software name is starting to look less broken, one biotech just got real M&A buzz, and one communications stock still has more moving parts than a garage project. We’ll break down which move looks most durable, which one is still just a trade, and which one needs a helmet before entry.

Defense Metal Watch (Sponsored)
Earlier this year, a U.S. defense-linked consortium issued a request for proposals focused on nickel supply and related processing capacity.
One micro-cap subsea mining company has now responded with a formal bid, positioning itself within a supply chain conversation that has become increasingly urgent.
The backdrop is a growing push to secure domestic or allied sources of strategic materials used in advanced manufacturing and military systems.
It is still an early-stage story, but the filing marks more than a concept on paper.
View the Report
*This communication is a paid advertisement published by Capital Gain Media Incorporated and does not constitute a recommendation, offer, or solicitation to buy or sell securities. Capital Gain Media Incorporated has been compensated by Deep Sea Minerals Corp. with four hundred thousand dollars (USD 400,000) plus applicable taxes for an ongoing marketing campaign, which includes the publication of this communication. This compensation constitutes a significant conflict of interest with respect to our impartiality. This communication is for entertainment and informational purposes only. Never invest solely on the basis of our communications. The owner of Capital Gain Media may buy or sell securities of this issuer for its own profit. Resource exploration and development is highly speculative and involves significant inherent risks. There is no guarantee that Deep Sea Minerals Corp will generate a return on investment. All forward-looking statements involve risks and uncertainties. Past performance is not indicative of future results. Investors should conduct their own due diligence and consult a licensed financial advisor before making any investment decisions. For complete risk factors, refer to Deep Sea Minerals Corp.'s continuous disclosure documents available at www.sedarplus.ca.

Futures at a Glance📈
Futures are bouncing as fresh peace-talk chatter with Iran knocks oil prices lower and gives traders a reason to unclench a little. Right now, this still looks like an oil-first market, so if crude keeps cooling, stocks may finally get a cleaner morning.


Want to make sure you never miss a pre-market alert?
Elite Trade Club now offers text alerts — so you get trending stocks and market-moving news sent straight to your phone before the bell.
Email’s great. Texts are faster.
You’ll be first in line when the market starts moving.

What to Watch
Earnings (Premarket):
• PDD Holdings Inc. [PDD]
• Paychex, Inc. [PAYX]
• Chewy, Inc. [CHWY]
• Kingsoft Cloud Holdings Limited [KC]
Earnings (Aftermarket):
• Karman Holdings Inc. [KRMN]
• JBS N.V. [JBS]
• Jefferies Financial Group Inc. [JEF]
• Celcuity Inc. [CELC]
Earnings (Time Not Supplied):
• Cintas Corporation [CTAS]
• ICON plc [ICLR]
Economic Reports:
• Import price index (Feb): 8:30 am
• Import price index minus fuel (Feb): 8:30 am
Fed Speakers:
• Federal Reserve governor Stephen Miran speaks: 4:10 pm

Software
Braze Inc. is trying to Prove Growth Still Counts Even When Profits Are Late

Braze Inc [BRZE] is getting a nice pop, and the story is pretty simple: revenue is still growing, customers are still spending more, and the market is willing to forgive a lot when a software name shows it still has some pulse. The company is not profitable yet, which is the part that keeps value people rolling their eyes, but it is clearly still finding ways to expand with existing customers while adding new ones to the pile. That is not nothing in this market.
What investors are responding to is the feeling that Braze may still have a real runway, not just a buzzword collection and a slide deck with gradients. Monthly usage is growing, the customer count is moving higher, and retention is solid enough to suggest the product is not just a trial run people forget about after lunch. The company is spending heavily on growth, AI tools, and expansion, which hurts the bottom line now but gives the market something to imagine later. Software investors love later. Sometimes maybe too much.
The caution sign is obvious. Revenue growth is good, but losses still exist, margins are under pressure, and the market can get impatient quickly if the promised leverage takes too long to show up. A bounce can happen fast. So can a mood swing. This is still a prove-it story dressed in a nicer shirt.
My Take For You: Fine for a small starter if it holds the pop, but do not chase it like profitability just showed up with flowers.
My Verdict: Improving setup with real growth, but still a watch-list type for anyone who prefers cleaner earnings.

Biotech
Terns Pharmaceuticals Just Got the Kind of Rumor That Makes Biotech Traders Forget to Blink

Terns Pharmaceuticals Inc [TERN] is flying because takeover chatter is now doing what takeover chatter does best, which is making people imagine a press release before breakfast. The report says Merck may be circling with a deal around $6 billion, and that is more than enough to turn a regular biotech morning into a full-on rumor carnival. When a big pharma name shows up in the gossip, traders do not exactly wait for engraved invitations.
The reason this rumor has legs is that it actually makes some sense. Terns has an oncology asset that fits neatly into a larger drugmaker’s shopping list, and Merck has been acting like someone who knows patent cliffs do not solve themselves. So this is not just random internet smoke from a basement with bad lighting. There is a business logic to it, which is why the stock is getting treated like the music might still have another chorus.
That said, rumor trades are still rumor trades. Until paperwork shows up, the stock is basically balancing on excitement and possibility. If the deal comes, great. If it does not, gravity usually remembers where the stock lives. So yes, the setup is juicy. No, that does not mean you should buy it like a guaranteed wedding gift.
My Take For You: If you play this, keep it small and treat it like a trade, not a forever love story. If you already own it, trimming into strength is fair.
My Verdict: Great rumor setup with believable logic, but still pure event risk until the ink dries.

Energy Opportunity (Sponsored)
The recent move in oil prices has put the energy sector back in focus.
Large banks have raised their outlooks for crude, and investors are reexamining which companies could benefit most if supply risks remain elevated.
In a new report, Zacks highlights three oil stocks that stand out based on the current market backdrop.
View the briefing.
*The results listed above are not (or may not be) representative of the performance of all selections made by Zacks Investment Research's newsletter editors and may represent the partial close of a position. Access grants you a comprehensive list of all open and closed trades.
*This free resource is being sent by Zacks.com. We look for investment resources and inform you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms of Service".

Communications
EchoStar Corp Has More Moving Parts Than a Garage Project, and the Market Still Finds It Interesting

EchoStar Corp [SATS] is one of those stocks where the headline numbers can look ugly enough to scare off normal people, yet the market keeps hanging around because the asset story is still weirdly intriguing.
Yes, the company posted a monster loss, and yes, the pay-TV business continues to shrink like a sweater in a bad dryer cycle. But investors are clearly more interested in what sits under the hood, like the spectrum, the wireless strategy shift, and other assets that may be worth more than the mess makes obvious at first glance.
That is the appeal here. This is less about loving the current business and more about squinting hard at the parts and asking whether the market has gotten too dramatic. The wireless losses have improved a bit, the asset pile still has value, and short interest keeps this thing spicy enough for traders to care. It is not exactly a clean growth story. It is more like a cluttered attic where somebody keeps insisting there might be a Picasso under the old lamps.
The problem is that clutter can stay clutter for a long time. Asset value stories are great until the market gets bored waiting for value to unlock. Meanwhile, the operating business still has real issues, and ugly numbers can keep scaring buyers away.
My Take For You: Interesting for a speculative nibble only, especially on pullbacks. Just know you are betting on hidden value, not clean execution.
My Verdict: Messy but intriguing. Worth watching if you like complicated stories, but definitely not a sleep-well-at-night stock.

Trivia: Which of these is NOT on U.S. currency?

Movers and Shakers

DigitalOcean Holdings Inc [DOCN]: Premarket Move: -7%
DigitalOcean Holdings Inc [DOCN] is getting bonked after announcing a big stock offering, which is Wall Street’s favorite way of saying thanks for the rally, now please share.
The company says it wants more data center capacity and a cleaner balance sheet, which sounds responsible, but in the short term, this usually feels like showing up to a pizza party and learning everyone now gets thinner slices.
My Take: The long-term story may still be fine, but offerings tend to put a lid on things for a bit. Let it settle and see where the new floor shows up before trying to be clever.
CF Industries Holdings, Inc. [CF]: Premarket Move: -5%
CF Industries Holdings, Inc. [CF] looks like it is giving back some of its war premium now that traders are sniffing out a possible path to cooler headlines with Iran.
Fertilizer names got a boost when energy and geopolitical panic were running hot, so now that oil is calming down a bit, this one looks like it is losing some of that extra juice.
My Take: This feels more like hot money leaving than a broken business. Still, do not rush in front of the slide. Wait for the commodity mood to settle, then see if buyers come back.
Enliven Therapeutics Inc [ELVN]: Premarket Move: +17%
Enliven Therapeutics Inc [ELVN] is flying after a target hike tied to encouraging CML data, and biotech traders love nothing more than a promising readout with a fresh analyst blessing on top.
The company still has more to prove, but right now the story is simple: the data looked good enough to make people imagine a much bigger future.
My Take: Nice momentum, but biotech pops can turn into pogo sticks. Fine for a small speculative bite if it holds up after the open, but do not chase it like the next update is guaranteed to be a parade.

Trump Investment Watch (Sponsored)
The Trump Administration is Loading Up on Stocks.
15% Stake in MP Materials... Up 216% in 4 Months.
10% Stake in Lithium Americas... A triple in 3 weeks.
10% Stake in Trilogy Metals... Up 388% in 8 days!
Why America's Economist Predicts THIS Could Be the Administration's Next Big Stock Buy.

Everything Else
Private credit is starting to show more cracks, and worries about loan quality are getting louder.
Pop Mart says Labubu is still carrying the party, while other monster lines are moving more slowly.
A jury reached a verdict in the Meta child safety case, which is not the kind of court headline tech investors enjoy.
Meta was ordered to pay $375 million in the New Mexico case over child exploitation claims.
OpenAI is reportedly getting ready to shut down the standalone Sora video app.

That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.
Best Regards,
— Adam Garcia
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.




